Your Lung Operation Booklet
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Nonintubated Thoracoscopic Surgery Using Regional Anesthesia and Vagal Block and Targeted Sedation
Original Article Nonintubated thoracoscopic surgery using regional anesthesia and vagal block and targeted sedation Ke-Cheng Chen1,2, Ya-Jung Cheng3, Ming-Hui Hung3, Yu-Ding Tseng1, Jin-Shing Chen1,2 1Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin County, Taiwan; 2Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 3Department of Anesthesiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan Corresponding to: Dr. Jin-Shing Chen. Department of Surgery, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei, Taiwan. Email: [email protected]. Objective: Thoracoscopic surgery without endotracheal intubation is a novel technique for diagnosis and treatment of thoracic diseases. This study reported the experience of nonintubated thoracoscopic surgery in a tertiary medical center in Taiwan. Methods: From August 2009 through August 2013, 446 consecutive patients with lung or pleural diseases were treated by nonintubated thoracoscopic surgery. Regional anesthesia was achieved by thoracic epidural anesthesia or internal intercostal blockade. Targeted sedation was performed with propofol infusion to achieve a bispectral index value between 40 and 60. The demographic data and clinical outcomes were evaluated by retrospective chart review. Results: Thoracic epidural anesthesia was used in 290 patients (65.0%) while internal intercostal blockade was used in 156 patients (35.0%). The final diagnosis were primary lung cancer in 263 patients (59.0%), metastatic lung cancer in 38 (8.5%), benign lung tumor in 140 (31.4%), and pneumothorax in 5 (1.1%). The median anesthetic induction time was 30 minutes by thoracic epidural anesthesia and was 10 minutes by internal intercostal blockade. -
The Role of Surgery in the Treatment of Pulmonary TB and Multidrug- and Extensively Drug-Resistant TB
The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB ABSTRACT The global spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of M. tuberculosis have resulted in a resurgence of almost incurable and even fatal cases for which only a few therapeutic options are available. Surgery has been applied to improve treatment success rates in MDR-TB patients and a combined medical and surgical approach is increasingly being used to treat patients with M/XDR-TB. The effectiveness of surgery in the management of pulmonary TB (particularly MDR-TB) has not, however, been documented and evaluated, its role in the Tuberculosis Control Programme is not well-established and practices vary across the WHO European Region. The WHO Regional Office for Europe has decided, in collaboration with the Member States and other partners, to review existing practices and lessons learned and to document expert opinion based on the available evidence and consensus among the members of the European Task Force on the role of Surgery in MDR- TB. This consensus paper should not be considered as recommendations from WHO but as a document of expert opinion based on current evidence, which presents indications and contraindications for surgical treatment of pulmonary TB and M/XDR-TB, the conditions for and timing of surgery, types of operation, and preoperative and postoperative management. Keywords POSTOPERATIVE CARE SURGERY TUBERCULOSIS, EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, MULTIDRUG-RESISTANT TUBERCULOSIS, PULMONARY Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe UN City, Marmorvej 51 DK-2100 Copenhagen Ø, Denmark Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office website (http://www.euro.who.int/pubrequest). -
Sublobectomy Is a Safe Alternative for Localized Cavitary Pulmonary
Yang et al. Journal of Cardiothoracic Surgery (2021) 16:22 https://doi.org/10.1186/s13019-021-01401-5 RESEARCH ARTICLE Open Access Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis Yong Yang1†, Shaojun Zhang2†, Zhengwei Dong3, Yong Xu1, Xuefei Hu1, Gening Jiang1, Lin Fan2* and Liang Duan1* Abstract Objective: Surgical resection plays an essential role in the treatment of Pulmonary Tuberculosis (PTB). There are few reports comparing lobectomy and sublobectomy for pulmonary TB with cavity. To compare the advantages between lobectomy and sublobectomy for localized cavitory PTB, we performed a single-institution cross sectional cohort study of the surgical patients. Methods: We consecutively included 203 patients undergoing lobectomy or sublobectomy surgery for localized cavitary PTB. All patients were followed up, recorded and compared their surgical complication, outcome and associated characteristics. Results: Both groups had similar outcomes after follow up for 13.1 ± 12.1 months, however, sublobectomy group suffered fewer intraoperative blood losses, shorter length of stay, and fewer operative complications than lobectomy group (P < 0.05). Both groups obtained satisfactory outcome with postoperatively medicated for similar period of time and few relapse (P > 0.05). Conclusion: Both sublobectomy and lobectomy resection were effective ways for cavitary PTB with surgical indications. If adequate anti-TB chemotherapy had been guaranteed, sublobectomy is able to be recommended due to more lung parenchyma retain, faster recover, and fewer postoperative complications. Keywords: Pulmonary tuberculosis, Cavity, Lobectomy, Sublobectomy, Complication, Prognosis Introduction observed in clinic. It accounts for more than 40% of Tuberculosis (TB) is still a major public health threat adults with PTB [3, 4]. -
Both Left Upper Lobectomy and Left Pneumonectomy Are Risk Factors For
www.nature.com/scientificreports OPEN Both left upper lobectomy and left pneumonectomy are risk factors for postoperative stroke Received: 12 December 2018 Nanchang Xie1, Xianghe Meng1, Chuanjie Wu2, Yajun Lian1, Cui Wang3, Mengyan Yu1, Accepted: 8 July 2019 Yingjiao Li1 & Yali Wang1 Published: xx xx xxxx Retrospective studies have found that left upper lobectomy (LUL) may be a new risk factor for stroke, and the potential mechanism is pulmonary vein thrombosis, which more likely develops in the left superior pulmonary vein (LSPV) stump. The LSPV remaining after left pneumonectomy is similar to that remaining after LUL. However, the association between left pneumonectomy, LUL, and postoperative stroke remains unclear. Thus, we sought to analyze whether both LUL and left pneumonectomy are risk factors for postoperative stroke. We prospectively included consecutive patients who underwent resection between November 2016 and March 2018 at our institution with 6 months of follow-up. Baseline demographic and clinical data were taken. A logistic regression model was used to determine independent predictors of postoperative stroke. In our study, 756 patients who underwent an isolated pulmonary lobectomy procedure were screened; of these, 637 patients who completed the 6-month follow-up were included in the analysis. Multivariable logistic regression analysis adjusted for common risk factors showed that the LUL and left pneumonectomy were independent predictors of stroke (odds ratio, 18.12; 95% confdence interval, 2.12–155.24; P = 0.008). Moreover, diabetes mellitus also was a predictor of postoperative stroke. In conclusion, both LUL and left pneumonectomy are signifcant risk factors for postoperative stroke. Stroke is one of the most feared complications of surgery, which occurs in 0.08–0.7% and 0.6% of general and thoracic surgery patients, respectively1–3. -
Answer Key Chapter 1
Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6. -
Endoscopy Matrix
Endoscopy Matrix CPT Description of Endoscopy Diagnostic Therapeutic Code (Surgical) 31231 Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) X 31233 Nasal/sinus endoscopy, diagnostic with maxillary sinusoscopy (via X inferior meatus or canine fossa puncture) 31235 Nasal/sinus endoscopy, diagnostic with sphenoid sinusoscopy (via X puncture of sphenoidal face or cannulation of ostium) 31237 Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or X debridement (separate procedure) 31238 Nasal/sinus endoscopy, surgical; with control of hemorrhage X 31239 Nasal/sinus endoscopy, surgical; with dacryocystorhinostomy X 31240 Nasal/sinus endoscopy, surgical; with concha bullosa resection X 31241 Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery X 31253 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior), including frontal sinus exploration, with removal of tissue from frontal sinus, when performed 31254 Nasal/sinus endoscopy, surgical; with ethmoidectomy, partial (anterior) X 31255 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior 31256 Nasal/sinus endoscopy, surgical; with maxillary antrostomy X 31257 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior), including sphenoidotomy 31259 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior), including sphenoidotomy, with removal of tissue from the sphenoid sinus 31267 Nasal/sinus endoscopy, surgical; with removal of -
Anesthesia for Video-Assisted Thoracoscopic Surgery
23 Anesthesia for Video-Assisted Thoracoscopic Surgery Edmond Cohen Historical Considerations of Video-Assisted Thoracoscopy ....................................... 331 Medical Thoracoscopy ................................................................................................. 332 Surgical Thoracoscopy ................................................................................................. 332 Anesthetic Management ............................................................................................... 334 Postoperative Pain Management .................................................................................. 338 Clinical Case Discussion .............................................................................................. 339 Key Points Jacobaeus Thoracoscopy, the introduction of an illuminated tube through a small incision made between the ribs, was • Limited options to treat hypoxemia during one-lung venti- first used in 1910 for the treatment of tuberculosis. In 1882 lation (OLV) compared to open thoracotomy. Continuous the tubercle bacillus was discovered by Koch, and Forlanini positive airway pressure (CPAP) interferes with surgi- observed that tuberculous cavities collapsed and healed after cal exposure during video-assisted thoracoscopic surgery patients developed a spontaneous pneumothorax. The tech- (VATS). nique of injecting approximately 200 cc of air under pressure • Priority on rapid and complete lung collapse. to create an artificial pneumothorax became a widely used • Possibility -
Pulmonary Function Changes Over 1 Year After Lobectomy in Lung Cancer
RESPIRATORY CARE Paper in Press. Published on November 24, 2015 as DOI: 10.4187/respcare.04284 Pulmonary Function Changes Over 1 Year After Lobectomy in Lung Cancer Hyun Koo Kim MD PhD, Yoo Jin Lee MSc, Kook Nam Han MD PhD, and Young Ho Choi MD PhD BACKGROUND: This study was conducted to measure the serial changes in pulmonary function over 12 months after lobectomy in subjects with lung cancer and to evaluate the actual recovery of pulmonary function in comparison with the predicted postoperative values. METHODS: Subjects who underwent lobectomy for primary lung cancer were included in this study. In the statistical analysis, we included data from 76 subjects (52 men and 24 women; mean age, 63.4 y) who completed perfusion scintigraphy 1 week before surgery and FEV1 and diffusion capacity of the lung for carbon monoxide (DLCO) assessments preoperatively and at 1, 6, and 12 months postop- eratively. RESULTS: The actual percent-of-predicted FEV1 1 month postoperatively was 77.9% of the preoperative value, which was almost equal to the predicted postoperative value, and signifi- cantly increased to 84.3% by 6 months and 84.2% at 12 months. The actual percent-of-predicted DLCO 1 month postoperatively was 81.8% of the preoperative value, which was similar to the predicted postoperative value, and also significantly increased to 91.3% at 6 months and 96.5% at 12 months. However, the actual pulmonary function test results at1yinsubjects with COPD or in those who underwent thoracotomy or received adjuvant chemotherapy were not different from the predicted postoperative values. -
Video-Assisted Thoracoscopic Surgery (VATS)
AY 130108 Video-assisted thoracoscopic surgery Jay B. Brodskya and Edmond Cohenb Video-assisted thoracic surgery is finding an ever-increasing Introduction role in the diagnosis and treatment of a wide range of thoracic Thoracoscopy involves intentionally creating a pneu- disorders that previously required sternotomy or open mothorax and then introducing an instrument through thoracotomy. The potential advantages of video-assisted the chest wall to visualize the intrathoracic structures. thoracic surgery include less postoperative pain, fewer Direct visual inspection of the pleural cavity has been operative complications, shortened hospital stay and reduced performed since 1910, when Jacobeaus ®rst used a costs. The following review examines the surgical and thoracoscope to diagnose and treat effusions secondary anesthetic considerations of video-assisted thoracic surgery, to tuberculosis. The recent application of video cameras with an emphasis on recently published articles. Curr Opin to thoracoscopes for high-de®nition magni®ed viewing, Anaesthesiol 13:000±000. # 2000 Lippincott Williams & Wilkins. coupled with the development of sophisticated surgical instruments and stapling devices, has greatly expanded the ability of the endoscopist to do increasingly more complex procedures using thoracoscopy. aDepartment of Anesthesiology, Stanford University School of Medicine, Stanford, California, USA; and bDepartment of Anesthesiology, The Mount Sinai Medical Center, New York, NY, USA Compared with open thoracotomy, video-assisted thor- acoscopic surgery (VATS) is considered to be `minimally Correspondence to Jay B Brodsky at the Department of Anesthesiology, Stanford University School of Medicine, Stanford, CA 94305, USA Tel: +1 650 725 5869; invasive'. The patient population tends to be either very fax: +1 650 725 8544; email: [email protected] healthy individuals undergoing diagnostic procedures, or Current Opinion in Anaesthesiology 2000, 13:000±000 high-risk patients undergoing VATS to avoid open thoracotomy. -
Anesthesia for Minimally Invasive Thoracic Surgery
Thoracic Anesthesia Can Be a Pleasure! Tips and Tricks For Maximizing Success Karen Sibert, MD Associate Clinical Professor Department of Anesthesiology & Perioperative Medicine David Geffen School of Medicine at UCLA UCLA Health Despite advances in diagnosis and treatment in many areas of oncology, lung cancer remains a deadly disease and is the major source of the increasing caseload of thoracic surgery procedures today. A steadily increasing proportion of these cases are diagnosed in women. Complete surgical excision of tumor remains the only hope of cure. With more cardiac procedures moving from the OR to the cardiac catheterization laboratory, many cardiac surgeons are returning for fellowships in the burgeoning field of minimally invasive thoracic surgery. Only about 14% of lung carcinomas are of the small cell type; the remainder are squamous or adenocarcinomas which are operable if diagnosed early. Anesthesia for minimally invasive, video-assisted thoracic surgery (VATS) is similar to anesthesia for open thoracic cases in many respects. However, achieving lung isolation quickly and completely is even more important, since even a slightly inflated lung may obstruct the surgeon’s view. Procedures that are amenable to VATS include: Mediastinoscopy Wedge resection or lung biopsy Lobectomy or segmentectomy Pleurodesis, mechanical or talc, for pleural effusion or spontaneous pneumothorax Decortication, including evacuation of empyema or hemothorax Lung volume reduction as treatment for severe emphysema. Any patient may be a candidate regardless of extremes of age or pulmonary disease. Procedures still requiring open thoracotomy include pneumonectomy, tracheal resection, and chest wall resection. The advantages of VATS include decreased hospital length of stay, decreased morbidity, and the ability to do more cases per day in each OR. -
A Guide to Thoracic Surgery for Patients and Families
A Guide to Thoracic Surgery for Patients and Families Section of Thoracic Surgery Department of Surgery Welcome to Michigan Medicine Your surgery is scheduled for: _______________________________________________ Your surgeon has given you a date and time for your operation. We make every effort to keep your surgery on the original date, however it may be postponed or rescheduled if unexpected delays happen. If this occurs, everything possible will be done to reschedule you to the earliest available date. We apologize for any inconvenience this may cause. Understanding Your Thoracic Surgery This teaching book has been designed to prepare you for thoracic surgery. It provides you and your family with useful information about your surgical journey, as well as care before and after surgery. Take your time reading each section of the book before your surgery. Bring this book to the hospital for your surgery. This book has been divided into chapters that walk you through what type of surgery will have and then through the process of your surgery and recovery. There are descriptions for each specific procedure starting on (page 8). Use the table of contents to find the page number describing your surgery. Having someone guide you from first evaluation to recovery makes it easier to understand the process of thoracic surgery and eases your stress knowing there is a friendly, familiar face you can count on. That person is your Clinical Care Coordinator (CCC). This nurse helps you navigate the system, get scheduled for tests, provides education about the process and makes sure you get to all the right places at the right time. -
Tracheal and Bronchial Surgery
Tracheal and Bronchial Surgery 1A031 Honorary Editors: Douglas E. Wood, Douglas J. Mathisen, Erino Angelo Rendina Editors: Xiaofei Li, Federico Venuta, David C. van der Zee Associate Editors: Dirk Van Raemdonck, Federico Rea, Jinbo Zhao Xiaofei Li, Federico Venuta, David C. van der Zee Xiaofei Li, Federico Venuta, Editors: Tracheal and Bronchial Surgery Honorary Editors: Douglas E. Wood, Douglas J. Mathisen, Erino Angelo Rendina Editors: Xiaofei Li, Federico Venuta, David C. van der Zee Associate Editors: Dirk Van Raemdonck, Federico Rea, Jinbo Zhao AME Publishing Company Room C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong Information on this title: www.amegroups.com For more information, contact [email protected] Copyright © AME Publishing Company. All rights reserved. This publication is in copyright. Subject to statutory exception and to the provisions of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of AME Publishing Company. First published 2017 Printed in China by AME Publishing Company Editors: Xiaofei Li, Federico Venuta, David C. van der Zee Cover Image Illustrator: Zhijing Xu, Shanghai, China Tracheal and Bronchial Surgery Hardcover ISBN: 978-988-77841-8-0 AME Publishing Company, Hong Kong AME Publishing Company has no responsibility for the persistence or accuracy of URLs for external or third-party internet websites referred to in this publication, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. The advice and opinions expressed in this book are solely those of the author and do not necessarily represent the views or practices of AME Publishing Company.